Target intelligence / Profile preview

Divalent cation-dependent enzyme

Molecular classification
Enzyme
01

Overview

Divalent cation-dependent enzyme refers to a broad class of catalytic proteins that require the presence of two-plus charged metal ions, such as magnesium (Mg2+), zinc (Zn2+), or manganese (Mn2+), for their biological activity (Holm et al., 1996, Chemical Reviews). These ions typically reside within the enzyme active site, where they facilitate catalysis by stabilizing negative charges on transition states, activating nucleophiles like water, or properly orienting substrates (Andreini et al., 2008, Journal of Proteome Research). This category includes several high-profile therapeutic targets, such as HIV-1 integrase, matrix metalloproteinases (MMPs), and histone deacetylases (HDACs) (Pommier et al., 2005, Nature Reviews Drug Discovery; Overall and Kleifeld, 2006, Nature Reviews Cancer). Drugs targeting these enzymes often employ metal-binding groups, such as hydroxamates or carboxylates, to coordinate directly with the divalent cation and displace essential water molecules or substrates (Cohen, 2007, Current Opinion in Chemical Biology). Because these metal ions are ubiquitous and essential for the function of many different enzymes, a major challenge in drug design is achieving sufficient selectivity to avoid off-target toxicity (West and Johnstone, 2014, Journal of Clinical Investigation). Consequently, while these enzymes are vital targets for treating viral infections, cancer, and hypertension, their structural similarities require precise pharmacophore modeling to ensure safety and efficacy. The diversity of this class means that divalent cation-dependent enzyme is a functional grouping rather than a single protein family, encompassing a wide range of structural folds and biological pathways.

Other names
MetalloenzymeMetal-dependent enzymeCation-activated enzyme
02

Mechanism of action

Inhibition through coordination with active-site divalent cations, preventing substrate binding or transition state stabilization (Cohen, 2007, Current Opinion in Chemical Biology).

03

Biological functions

CatalysisDNA replicationRNA synthesisProtein degradationSignal transduction
04

Disease associations

InfectionCancerInflammationCardiovascular disease
05

Safety considerations

Off-target inhibition of related metalloenzymesSystemic metal ion chelationPotential for developmental toxicityGastrointestinal side effects
06

Interacting drugs

Raltegravir

6 more in the full profile.

07

Biomarkers

HIV-1 RNA viral loadBlood pressureHistone acetylation levelsMMP-9 levels

Beyond the preview

Go deeper on Divalent cation-dependent enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Divalent cation-dependent enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call